Iovance Biotherapeutics Inc (IOVA)

Jan 10, 2026

Iovance Highlights Amtagvi Momentum and Confirms 2025 Guidance - The Globe and Mail

Jan 10, 2026

Jan 10, 2026

Why Iovance Biotherapeutics Inc. stock appeals to dividend seekersWeekly Stock Analysis & Accurate Intraday Trading Signals - ulpravda.ru

Jan 10, 2026

Jan 09, 2026

Iovance Biotherapeutics, Inc. Updates Corporate Presentation - TradingView — Track All Markets

Jan 09, 2026

Jan 08, 2026

Why Iovance Biotherapeutics Inc. stock remains resilientJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

Why retail investors favor Iovance Biotherapeutics Inc. stockMarket Entry Points & Exceptional Return Growth - ulpravda.ru

Jan 07, 2026

Jan 04, 2026

Iovance Biotherapeutics (IOVA): Promising TIL Therapy Gains Momentum Amid Funding Challenges - MSN

Jan 04, 2026

Jan 02, 2026

Iovance Biotherapeutics Inc. (IOVA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 02, 2026

Jan 02, 2026

Iovance Biotherapeutics (NASDAQ:IOVA) Trading Down 7.1%Here's What Happened - MarketBeat

Jan 02, 2026

Dec 31, 2025

Why Iovance Biotherapeutics Stock Got Mashed on Monday - MSN

Dec 31, 2025

Dec 31, 2025

Barclays Adjusts Valuation Targets for Iovance Biotherapeutics (IOVA) Amid Biotech Sector Review - Insider Monkey

Dec 31, 2025

Dec 29, 2025

2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street - Finviz

Dec 29, 2025

Dec 29, 2025

Will Iovance Biotherapeutics Inc. stock attract more institutional investorsCovered Call Writing & Budget Friendly Investment Plans - bollywoodhelpline.com

Dec 29, 2025

Dec 29, 2025

Iovance Biotherapeutics: Bright Prospects For 2026 (NASDAQ:IOVA) - Seeking Alpha

Dec 29, 2025

Dec 23, 2025

The next front against cancer: A Mugglehead roundup - Mugglehead Magazine

Dec 23, 2025

Dec 23, 2025

Is Iovance (IOVA) Turning Talent Incentives and TIL Optimism Into a Durable Competitive Edge? - Sahm

Dec 23, 2025

Dec 23, 2025

Iovance Biotherapeutics (IOVA) Stock News Today: Barclays Raises Target, Short-Interest Pressure, and 2026 Catalysts (Dec. 23, 2025) - ts2.tech

Dec 23, 2025

Dec 22, 2025

Iovance Biotherapeutics: Is it Time to Invest? - StocksToTrade

Dec 22, 2025

Dec 22, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 8.7%Still a Buy? - MarketBeat

Dec 22, 2025

Dec 22, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(4) - marketscreener.com

Dec 22, 2025

Dec 20, 2025

Will Iovance Biotherapeutics Inc. stock outperform Nasdaq indexTrade Analysis Summary & Community Verified Trade Signals - ulpravda.ru

Dec 20, 2025

Dec 20, 2025

Iovance Biotherapeutics, Inc. $IOVA Position Increased by Squarepoint Ops LLC - MarketBeat

Dec 20, 2025

Dec 20, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Dec 20, 2025

Dec 19, 2025

Why Iovance Biotherapeutics Inc. stock attracts high net worth investors - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Iovance Biotherapeutics Inc. (2LB) stock valuation compares with sectorGap Down & Weekly High Return Stock Opportunities - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Cancer biotech offers stock options to new hires at $2.46 a share - Stock Titan

Dec 19, 2025

Dec 18, 2025

Market Trends: Is Iovance Biotherapeutics Inc. (2LB) stock cheap vs fundamentalsMarket Activity Report & Weekly High Return Forecasts - Улправда

Dec 18, 2025

Dec 18, 2025

There Is A Reason Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Price Is Undemanding - 富途牛牛

Dec 18, 2025

Dec 18, 2025

Iovance Biotherapeutics (IOVA) Stock News Today (Dec. 18, 2025): Barclays Lifts Target to $10, Analysts Stay Split on Amtagvi’s Launch - ts2.tech

Dec 18, 2025

Dec 18, 2025

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Given Consensus Rating of "Hold" by Brokerages - MarketBeat

Dec 18, 2025

Dec 17, 2025

Iovance Biotherapeutics Tries To Deliver On Cell Therapy Hopes - Finimize

Dec 17, 2025

Dec 17, 2025

Barclays Maintains Iovance Biotherapeutics (IOVA) Overweight Recommendation - Nasdaq

Dec 17, 2025

Dec 17, 2025

Barclays Doubles Iovance Biotherapeutics’ Price Target in Bold Market Move - StocksToTrade

Dec 17, 2025

Dec 17, 2025

Iovance Biotherapeutics (IOVA) Sees Raised Price Target by Barcl - GuruFocus

Dec 17, 2025

Dec 17, 2025

Iovance Biotherapeutics Advances Innovative Melanoma Treatment with Updated Study - TipRanks

Dec 17, 2025

Dec 17, 2025

Barclays’ Bullish Outlook Sparks Iovance Stock Surge - timothysykes.com

Dec 17, 2025

Dec 17, 2025

Mirador Capital Partners LP Makes New Investment in Iovance Biotherapeutics, Inc. $IOVA - MarketBeat

Dec 17, 2025

Dec 16, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 6.7%Should You Buy? - MarketBeat

Dec 16, 2025

Dec 16, 2025

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Cross Above Fifty Day Moving AverageHere's Why - MarketBeat

Dec 16, 2025

Dec 13, 2025

What analysts say about Iovance Biotherapeutics Inc 2LB stockLong-Term Investment Plans & Advanced Stock Screening Tools - earlytimes.in

Dec 13, 2025

Dec 13, 2025

Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA)Contact Levi & Korsinsky Before July 14, 2025 - ACCESS Newswire

Dec 13, 2025

Dec 08, 2025

Iovance Biotherapeutics Stock: Analyzing Its Surprising Surge - StocksToTrade

Dec 08, 2025

Dec 08, 2025

Will Iovance Biotherapeutics’ Stock Surge? - timothysykes.com

Dec 08, 2025

Dec 08, 2025

Iovance Biotherapeutics: A Surge or A Signal to Watch? - timothysykes.com

Dec 08, 2025

Dec 08, 2025

Iovance Biotherapeutics (IOVA): Is the Market Overlooking a Potential Rebound in Valuation After a Tough Year? - Yahoo Finance

Dec 08, 2025